Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia

International Journal of Laboratory Hematology

Volumn 30, Issue 6, 2008, Pages 508-512

  Kim, M ^a   Lee, S ^a   Jung, C K ^a   Lim, J ^a   Cho, S G ^a   Kim, D W ^a   Kim, Y ^a,b   Han, K ^a   Min, W S ^a   Kim, C C ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Chronic myelogenous leukemia; Imatinib mesylate; Trisomy 8

Indexed keywords

IMATINIB;

ADULT; ARTICLE; BONE MARROW EXAMINATION; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KARYOTYPING; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METAPHASE; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; TRISOMY 8;

ADULT; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; TRISOMY;

EID: 55149086358     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00991.x     Document Type: Article

References (14)

1. Anderson M.K., Pedersen-Bjergaard J., Kjeldsen L., Dufva I.H. Brøndum-Nielsen K. (2002) Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia 16, 1390 1395.
2. Bilhou-Nabera C., Marit G., Devianne I., Viard F., Salzes S., Montastruc M., Renoux M., Broustet A., Reiffers J. Bernard Ph. (1993) A second case of trisomy 8 in Philadelphia chromosome (Ph)-negative cells during the course of Ph-positive chronic myelocytic leukemia. Genes, Chromosomes and Cancer 6, 255 256.
3. Dietz A.B., Souan L., Knutson G.J., Bulur P.A., Litzow M.R. Vuk-Pavlovic S. (2004) Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. Blood 104, 1094 1099.
4. Druker B.J., Talpaz M., Resta D.J., Peng B., Buchdunger E., Ford J.M., Lydon N.B., Kantarjian H., Capdeville R., Ohno-Jones S. Sawyers C.L. (2001) Efficiency and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine 344, 1031 1037.
5. Fabarius A., Giehl M., Frank O., Duesberg P., Hochhaus A., Hehlmann R. Seifarth W. (2005) Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 19, 1573 1578.
6. Guilbert-Douet N., Morel F., Le Bris M.J., Berthou C., Morice P., Bourquard P. Braekeleer M.D. (2004) Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib. Leukemia 18, 1140 1142.
7. Jaffe E.S., Harris N.L., Stein H. Wardiman J.W. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
8. Kantarjian H., Sawyers C., Hochhaus A., Guilhot F., Schiffer C., Gambacorti-Passerini C., Niederwieser D., Resta D., Capdeville R., Zoellner U., Talpaz M. Druker B. (2002) Haematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. New England Journal of Medicine 346, 645 652.
9. Lin Y., Bruyère H., Horsman D.E., Pantzar T., Barnett M.J., Hogge D.E., Nevill T.J., Nantel S.H., Sutherland H.J., Toze C.L., Shepherd J.D., Lavoie J.C., Song K.W., Smith C.A. Forrest D.L. (2006) Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors. Cancer Genetics and Cytogenetics 170, 16 23.
10. McNamara C., Grigg A., Szer J., Roberts A., Campbell L., Hoyt R., Lynch K. Juneja S. (2003) Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukemia. Clinical and Laboratory Haematology 25, 119 125.
11. Neumann F., Teutsch N., Kliszewski S., Bork S., Steidl U., Brors B., Schimkus N., Roes N., Germing U., Hildebrandt B., Royer-Pokora B., Eils R., Gattermann N., Haas R. Kronenwett R. (2005) Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34 + hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib. Leukemia 19, 458 460.
12. O'Dwyer M.E., Gatter K.M., Loriaux M., Druker B.J., Olson S.B., Magenis R.E., Lawce H., Mauro M.J., Maziarz R.T. Braziel R.M. (2003) Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia 17, 481 487.
13. Tanaka H., Tanaka K., Oguma N., Ito K., Ito T., Kyo T., Dohy H. Kimura A. (2004) Effect of interferon-α on chromosome abnormalities in treated chronic myelogenous leukemia patients. Cancer Genetics and Cytogenetics 153, 133 143.
14. Terre C., Eclache V., Rousselot P., Imbert M., Charrin C., Gervais C., Mozziconacci M.J., Maarek O., Mossafa H., Auger N., Dastugue N., Talmant P., Van den Akker J., Leonard C., N'Guyen Khac F., Mugneret F., Biguié F., Lafage-Pochitaloff M., Bastie J.N., Roux G.L., Nicolini F., Maloisel F., Vey N., Laurent G., Recher C., Vigier M., Yacouben Y., Giraudier S., Vernant J.P., Salles B., Roussi J., Castaigne S., Leymarie V., Flandrin G. Lessard M. (2004) Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia 18, 1340 1346.